<DOC>
	<DOCNO>NCT01011738</DOCNO>
	<brief_summary>This observational , non-interventional cohort study evaluate predictor response patient chronic hepatitis B receive standard care Pegasys therapy . Efficacy safety parameter also evaluate . Patients include study follow duration treatment 3 year thereafter .</brief_summary>
	<brief_title>An Observational Cohort Study Patients With Chronic Hepatitis B Receiving Pegasys</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>adult patient , &gt; /= 18 year age chronic hepatitis B treatment peginterferon alfa2A coinfection HAV , HCV HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>